Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CD147-spike protein interaction in COVID-19: Get the ball rolling with a novel receptor and therapeutic target
Tapan Behl, Ishnoor Kaur, Lotfi Aleya, et al.
The Science of The Total Environment (2021) Vol. 808, pp. 152072-152072
Open Access | Times Cited: 94

Showing 1-25 of 94 citing articles:

ICAM-1 and VCAM-1: Gatekeepers in various inflammatory and cardiovascular disorders
Varinder Singh, Rupinder Kaur, Pratima Kumari, et al.
Clinica Chimica Acta (2023) Vol. 548, pp. 117487-117487
Closed Access | Times Cited: 122
Echinacea purpurea (L.) Moench: Biological and Pharmacological Properties. A Review
Cristina Burlou-Nagy, Florin Bănică, Tünde Jurca, et al.
Plants (2022) Vol. 11, Iss. 9, pp. 1244-1244
Open Access | Times Cited: 77
Covid-19 a triggering factor of autoimmune and multi-inflammatory diseases
Emina Karahmet Sher, Adnan Ćosović, Amina Džidić-Krivić, et al.
Life Sciences (2023) Vol. 319, pp. 121531-121531
Open Access | Times Cited: 42
Hemolytic anemia in COVID-19
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Ajeet Kaushik, et al.
Annals of Hematology (2022) Vol. 101, Iss. 9, pp. 1887-1895
Open Access | Times Cited: 43
Innate and Adaptive Immunity during SARS-CoV-2 Infection: Biomolecular Cellular Markers and Mechanisms
Brent Brown, Vanshika Ojha, Ingo Fricke, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 408-408
Open Access | Times Cited: 37
COVID-19 and atrial fibrillation: Intercepting lines
Maria Donniacuo, Antonella De Angelis, Concetta Rafaniello, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 24
Mutational dynamics of SARS-CoV-2: Impact on future COVID-19 vaccine strategies
Niloofar Faraji, Tahereh Zeinali, Farahnaz Joukar, et al.
Heliyon (2024) Vol. 10, Iss. 9, pp. e30208-e30208
Open Access | Times Cited: 11
Acute Myocardial Infarction during the COVID-19 Pandemic: Long-Term Outcomes and Prognosis—A Systematic Review
Marius Rus, Adriana Ioana Ardelean, Felicia Liana Andronie-Cioară, et al.
Life (2024) Vol. 14, Iss. 2, pp. 202-202
Open Access | Times Cited: 10
Cholesterol and COVID-19—therapeutic opportunities at the host/virus interface during cell entry
Thomas Grewal, Mai Khanh Linh Nguyen, Christa Buechler
Life Science Alliance (2024) Vol. 7, Iss. 5, pp. e202302453-e202302453
Open Access | Times Cited: 8
The Multisystem Impact of Long COVID: A Comprehensive Review
Nicoleta Negruț, Georgios Menegas, Sofia Kampioti, et al.
Diagnostics (2024) Vol. 14, Iss. 3, pp. 244-244
Open Access | Times Cited: 7
Comorbidities, Associated Diseases, and Risk Assessment in COVID-19—A Systematic Review
Andreea Fitero, Simona Bungău, Delia Mirela Ţiţ, et al.
International Journal of Clinical Practice (2022) Vol. 2022, pp. 1-24
Open Access | Times Cited: 33
Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants
William R. Strohl, Zhiqiang Ku, Zhiqiang An, et al.
BioDrugs (2022) Vol. 36, Iss. 3, pp. 231-323
Open Access | Times Cited: 32
Immune Response to SARS-CoV-2 Vaccines
Navya Bellamkonda, Upendra P. Lambe, Sonali Sawant, et al.
Biomedicines (2022) Vol. 10, Iss. 7, pp. 1464-1464
Open Access | Times Cited: 32
Mechanisms and clinical evidence to support melatonin's use in severe COVID-19 patients to lower mortality
Dun‐Xian Tan, Rüssel J. Reiter
Life Sciences (2022) Vol. 294, pp. 120368-120368
Open Access | Times Cited: 29
Reverse vaccinology approach for multi-epitope centered vaccine design against delta variant of the SARS-CoV-2
Khurshid Jalal, Kanwal Khan, Zarrin Basharat, et al.
Environmental Science and Pollution Research (2022) Vol. 29, Iss. 40, pp. 60035-60053
Open Access | Times Cited: 28
Therapeutic dilemmas in addressing SARS-CoV-2 infection: Favipiravir versus Remdesivir
Paul Andrei Negru, Andrei-Flavius Radu, Cosmin Mihai Vesa, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 147, pp. 112700-112700
Open Access | Times Cited: 27
SARS‐CoV‐2 induced HDL dysfunction may affect the host's response to and recovery from COVID‐19
Hayder M. Al‐kuraishy, Nawar Raad Hussien, Marwa S. Al‐Niemi, et al.
Immunity Inflammation and Disease (2023) Vol. 11, Iss. 5
Open Access | Times Cited: 20
Application of single-cell RNA sequencing on human testicular samples: a comprehensive review
Fan Dong, Ping Ping, Yi Ma, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 7, pp. 2167-2197
Open Access | Times Cited: 15
A mid‑pandemic night's dream: Melatonin, from harbinger of anti‑inflammation to mitochondrial savior in acute and long COVID‑19 (Review)
Ioannis Lempesis, Vasiliki Georgakopoulou, Rüssel J. Reiter, et al.
International Journal of Molecular Medicine (2024) Vol. 53, Iss. 3
Open Access | Times Cited: 5
Atorvastatin Attenuated the Inflammatory Outcomes of COVID-19: A Double-Blind, Randomized Controlled Trial
Hajar Shokri‐Afra, Sudabe Baghery moghadam, Ziaeddin Oladi, et al.
Journal of Reports in Pharmaceutical Sciences (2025) Vol. 13, Iss. 1
Open Access
COVID-19 IN THE CENTRAL NERVOUS SYSTEM: ROUTES OF ENTRY AND INFLUENCE ON GLIOMAGENESIS
Л. Б. Митрофанова, I. A. Makarov, K.A. Guseva, et al.
Molekulyarnaya Meditsina (Molecular medicine) (2025), pp. 40-48
Closed Access
Receptors and Cofactors That Contribute to SARS-CoV-2 Entry: Can Skin Be an Alternative Route of Entry?
Manon Barthe, Leslie Hertereau, Noura Lamghari, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6253-6253
Open Access | Times Cited: 14
SARS-CoV-2 infection of phagocytic immune cells and COVID-19 pathology: Antibody-dependent as well as independent cell entry
Olga V. Matveeva, Yury D. Nechipurenko, Denis Lagutkin, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 21
An Immunological Review of SARS-CoV-2 Infection and Vaccine Serology: Innate and Adaptive Responses to mRNA, Adenovirus, Inactivated and Protein Subunit Vaccines
Suhaila A. Al-Sheboul, Brent Brown, Yasemin Shboul, et al.
Vaccines (2022) Vol. 11, Iss. 1, pp. 51-51
Open Access | Times Cited: 18
SARS-CoV-2 S1 protein causes brain inflammation by reducing intracerebral acetylcholine production
Naomi Oka, Kazuya Shimada, Azusa Ishii, et al.
iScience (2023) Vol. 26, Iss. 6, pp. 106954-106954
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top